Volume 4; Issue 1

Main
HIV Medicine
Volume 4; Issue 1

HIV Medicine

Volume 4; Issue 1

1

Virological and immunological profiles among patients with undetectable viral load followed prospectively for 24 months

TL Katzenstein, H Ullum, BT Røge, J Wandall, E Dickmeiss, T Barrington, P Skinhøj, J Gerstoft

Journal:

Year:

2003

Language:

english

File:

PDF, 105 KB

english, 2003

2

Patterns of antiretroviral use in the United States of America: analysis of three observational databases

AC Ghani, CA Donnelly, RM Anderson

Journal:

Year:

2003

Language:

english

File:

PDF, 434 KB

english, 2003

3

Assessing limiting factors to the acceptance of antiretroviral therapy in a large cohort of injecting drug users

S Clarke, S Delamere, L McCullough, S Hopkins, C Bergin, F Mulcahy

Journal:

Year:

2003

Language:

english

File:

PDF, 64 KB

english, 2003

4

Discrepant results in the interpretation of HIV-1 drug-resistance genotypic data among widely used algorithms

GH Kijak, AE Rubio, SE Pampuro, C Zala, P Cahn, R Galli, JS Montaner, H Salomón

Journal:

Year:

2003

Language:

english

File:

PDF, 126 KB

english, 2003

5

Prevalence, risk factors and outcome of hyperlactataemia in HIV-infected patients

L Hocqueloux, C Alberti, J-P Feugeas, M Lafaurie, E Lukasiewicz, G Bagnard, O Carel, D Erlich, J-M Molina

Journal:

Year:

2003

Language:

english

File:

PDF, 72 KB

english, 2003

6

Drug resistance mutations and outcome of second-line treatment in patients with first-line protease inhibitor failure on nelfinavir-containing HAART

BT Røge, TL Katzenstein, HL Nielsen, J Gerstoft

Journal:

Year:

2003

Language:

english

File:

PDF, 102 KB

english, 2003

7

P-glycoprotein in blood CD4 cells of HIV-1-infected patients treated with protease inhibitors

P Bossi, O Legrand, A-M Faussat, M Legrand, F Bricaire, J-P Marie, H Agut, B Diquet, C Katlama, J-M Huraux, V Calvez

Journal:

Year:

2003

Language:

english

File:

PDF, 70 KB

english, 2003

8

The use of calcium carbonate in nelfinavir-associated diarrhoea in HIV-1-infected patients

S Jensen-Fangel, US Justesen, FT Black, C Pedersen, N Obel

Journal:

Year:

2003

Language:

english

File:

PDF, 64 KB

english, 2003

9

Long-term assessment of neuropsychiatric adverse reactions associated with efavirenz

P Lochet, H Peyrière, A Lotthé, JM Mauboussin, B Delmas, J Reynes

Journal:

Year:

2003

Language:

english

File:

PDF, 63 KB

english, 2003

10

Findings from the first national clinical audit of treatment for people with HIV

H Curtis, CA Sabin, MA Johnson, the British HIV Association Clinical Audit Committee

Journal:

Year:

2003

Language:

english

File:

PDF, 98 KB

english, 2003

11

Modelling the 3-year risk of myocardial infarction among participants in the Data Collection on Adverse Events of Anti-HIV Drugs (DAD) study

M Law, N Friis-Møller, R Weber, P Reiss, R Thiebaut, O Kirk, A D'Arminio Monforte, C Pradier, L Morfeldt, G Calvo, W El-Sadr, S De Wit, CA Sabin, JD Lundgren, for the DAD Study Group

Journal:

Year:

2003

Language:

english

File:

PDF, 111 KB

english, 2003